by Christopher Gloria, Senior Associate, Morrison Foerster The use of machine learning (ML) in the medical device field has greatly expanded in recent years, becoming increasingly important to the product offerings of many medical device companies. The benefits provided by …
Keep ReadingThe Importance of Patents for ML-Based Medical Device Inventions
by Emily Vernon, Innovation Analyst, RTI International Because of the imperative to innovate following the COVID-19 public health emergency (PHE), medical technology (medtech) mergers and acquisitions (M&A) are on the rise. Today, medtech players must collaborate to respond rapidly, develop …
Keep ReadingHow to Maintain a Competitive Edge in an Era of Increased M&A
by Brian Johnson, President, MassMEDIC Massachusetts is the heart of healthtech, with more than 420 medical device companies calling the Commonwealth home. The industry is an essential part to our economy, representing one out of every four products exported by …
by Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices, Johnson & Johnson COVID-19 has solidified to the world the importance of health care. It has shown us how we can propel our ingenuity forward and deliver life-saving innovations with …
Keep ReadingAddressing Health Disparities and Improving Access to Care in a Post-COVID World
By Brian Chapman Brian is a principal at ZS and leads the medtech practice. He has worked with companies on a range of sales and marketing issues, including sales force effectiveness, organizational design, opportunity assessment, channel design, new product launch …
Keep ReadingPatient Engagement Moves Medtech to the Front of the Line
by Jeff Mirviss, President, Peripheral Interventions at Boston Scientific Note: This blog post first appeared in the Star Tribune Medical Alley is the Silicon Valley of American healthcare. Our region is home to the world’s leading health technology cluster, the …
Keep ReadingPost-COVID innovation: How U.S. medtech can capitalize on this moment
By Joseph Zabinski, PhD, Senior Director of AI & Precision Medicine, OM1 As innovation in devices and diagnostics accelerates, research approaches and outcomes programs also need to advance to support these developments with high-quality evidence. At the same time, demonstrating …
